Valproic Acid
Brain Ischemia
University of North Carolina, Chapel HillSmall moleculePhase 4 / ApprovedActive
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 95/ 100
Competitive context
8 Active assets in the Brain Ischemia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Acetylsalicylic Acid City Clinical Hospital No. 67, Moscow, Russia | Phase 4 | BB |
Dipyridamole UMC Utrecht | Phase 4 | BB |
Sovateltide Pharmazz, Inc. | Phase 3 | BB |
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril Asan Medical Center | Phase 4 | BB |
Probucol Asan Medical Center | Phase 4 | BB |
View all 36 →
Same molecule, other indications
Valproic Acid is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →